996
Participants
Start Date
April 18, 2024
Primary Completion Date
August 25, 2025
Study Completion Date
January 16, 2026
Flu Pandemic mRNA_Dose level 1
2 doses of study intervention are administered to participants intramuscularly.
Flu Pandemic mRNA_Dose level 2
2 doses of study intervention are administered to participants intramuscularly.
Flu Pandemic mRNA_ Dose level 3.
2 doses of study intervention are administered to participants intramuscularly.
Flu Pandemic mRNA_ Dose level 4
2 doses of study intervention are administered to participants intramuscularly.
Flu Pandemic mRNA_Dose level 5
2 doses of study intervention are administered to participants intramuscularly.
Flu Pandemic mRNA_Dose level 6
2 dose of study intervention is administered to participants intramuscularly.
Influenza virus vaccine
2 doses of Influenza virus vaccine are administered to participants intramuscularly.
Placebo
2 doses of Placebo are administered intramuscularly to participants in Phase 1 and Phase 2 Part A and 2 dose is administered to participants in Phase 2 Part B.
RECRUITING
GSK Investigational Site, Rochester
RECRUITING
GSK Investigational Site, Philadelphia
RECRUITING
GSK Investigational Site, Norfolk
RECRUITING
GSK Investigational Site, Winston-Salem
RECRUITING
GSK Investigational Site, Greensboro
RECRUITING
GSK Investigational Site, Chamblee
RECRUITING
GSK Investigational Site, West Palm Beach
RECRUITING
GSK Investigational Site, Fort Myers
RECRUITING
GSK Investigational Site, Anniston
RECRUITING
GSK Investigational Site, Lexington
RECRUITING
GSK Investigational Site, Kansas City
RECRUITING
GSK Investigational Site, Lenexa
RECRUITING
GSK Investigational Site, El Dorado
RECRUITING
GSK Investigational Site, Omaha
RECRUITING
GSK Investigational Site, Little Rock
RECRUITING
GSK Investigational Site, Edmond
RECRUITING
GSK Investigational Site, Yukon
RECRUITING
GSK Investigational Site, Austin
RECRUITING
GSK Investigational Site, Fort Collins
RECRUITING
GSK Investigational Site, Las Vegas
RECRUITING
GSK Investigational Site, Seattle
Lead Sponsor
GlaxoSmithKline
INDUSTRY